subject: UMLS:C5202845

object_name: Tumor Mass


subject: UniProtKB:Q9QUL7

subject_name: TRYG1_MOUSE Tryptase gamma (sprot)

object_name: Muscle Invasive Bladder Carcinoma

tested_intervention: unsure


subject: UniProtKB:Q9QUL7

object_name: neoplasm


subject: UniProtKB:Q9QUL7


subject: PR:000016593

subject_name: tryptase gamma


subject: PR:000016593


subject: PR:000016593


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:7421


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:60791

subject_name: Xylocard

object_name: progressive bulbar palsy


subject: CHEBI:60791

object_name: Bulbar palsy


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: UMLS:C5197951

object_name: type 2 diabetes mellitus

tested_intervention: yes


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Fragility fracture


subject: CHEBI:74705

object_name: Complication of dialysis


subject: CHEBI:74705

object_name: kidney disorder


subject: CHEBI:74705

object_name: Renal rickets


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UNII:29DKI2H2NY

subject_name: Tinostamustine

object_name: Relapse multiple myeloma


subject: UNII:29DKI2H2NY

object_name: Plasma cell myeloma recurrent


subject: UNII:29DKI2H2NY

object_name: Multiple myeloma progression


subject: UNII:29DKI2H2NY

object_name: Multiple myeloma, without mention of having achieved remission


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant

object_name: hereditary angioedema


subject: CHEBI:231683

subject_name: Anakinra

object_name: atopic eczema


subject: CHEBI:231683

object_name: dermatitis


subject: CHEBI:231683

object_name: Eczema, CTCAE


subject: CHEBI:231683

object_name: Allergy


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PR:000001137


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: asthma


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: thyroid tumor


subject: CHEBI:75045

object_name: thyroid gland carcinoma


subject: CHEBI:75045

object_name: thyroid cancer


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:188074

object_name: diabetes mellitus


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: PUBCHEM.COMPOUND:71452493

subject_name: Procalcitonin

object_name: Fever


subject: PUBCHEM.COMPOUND:71452493

object_name: Fever symptoms (finding)


subject: PUBCHEM.COMPOUND:71452493

object_name: Fever, CTCAE


subject: PUBCHEM.COMPOUND:71452493

object_name: systemic inflammatory response syndrome


subject: UNII:SV1QL0ZSJ9

subject_name: PROCALCITONIN


subject: UNII:SV1QL0ZSJ9


subject: UNII:SV1QL0ZSJ9


subject: UNII:SV1QL0ZSJ9


subject: PR:000050333

subject_name: procalcitonin


subject: PR:000050333


subject: PR:000050333


subject: PR:000050333


subject: MESH:D011080

subject_name: Polychloroterphenyl Compounds


subject: MESH:D011080


subject: MESH:D011080


subject: MESH:D011080


subject: CHEBI:43871

subject_name: Fasudil

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:43871

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:155801560

subject_name: Sunobinop

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:155801560

object_name: alcohol dependence


subject: DRUGBANK:DB18955


subject: DRUGBANK:DB18955


subject: RXCUI:1040052

subject_name: dextromethorphan / quinidine Oral Capsule


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: prostate carcinoma


subject: UNII:PQX0D8J21J

object_name: prostate cancer


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:31859

subject_name: Modafinil

object_name: traumatic encephalopathy


subject: CHEBI:31859

object_name: traumatic brain injury


subject: CHEBI:31859

object_name: severe traumatic brain injury


subject: CHEBI:28230

subject_name: Hesperetin

object_name: Hunger


subject: PUBCHEM.COMPOUND:5245480

object_name: primary biliary cholangitis


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:63610

subject_name: Misoprostol

object_name: incomplete abortion


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: type 2 diabetes mellitus


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: uveitis


subject: UNII:B72HH48FLU

object_name: Uveitis, CTCAE


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:79699

object_name: clear cell renal carcinoma


subject: CHEBI:79699

object_name: renal cell adenocarcinoma


subject: CHEBI:79699

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:9821941

subject_name: lumateperone

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:9821941

object_name: bipolar depression


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: coronary artery disorder


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: hypertension


subject: CHEBI:3654

object_name: Hypertension, CTCAE


subject: CHEBI:51368

subject_name: Lofexidine

object_name: Opioid withdrawal


subject: UNII:NQ99E8OH3P

subject_name: Rilematovir

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C4733425

subject_name: Olimel Peri 2.5%

object_name: Weight loss


subject: UMLS:C4733425

object_name: Weight Loss, CTCAE


subject: UMLS:C4733425

object_name: pancreatic neoplasm


subject: UMLS:C4733425

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4733425

object_name: malignant pancreatic neoplasm


subject: UMLS:C4733425

object_name: biliary tract cancer


subject: UMLS:C4733425

object_name: liver carcinoma


subject: CHEBI:135905

subject_name: Terlipressin

object_name: hepatorenal syndrome


subject: CHEBI:52717

subject_name: Bortezomib

object_name: diffuse large B-cell lymphoma


subject: UNII:6WS4C399GB

subject_name: Lenograstim

object_name: B-cell neoplasm


subject: UNII:6WS4C399GB


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Acute Stroke


subject: CHEBI:107736

object_name: Acute Stroke Related to COVID-19


subject: CHEBI:107736

object_name: Dysphagia


subject: CHEBI:107736

object_name: Dysphagia, CTCAE


subject: CHEBI:167204

subject_name: Mosapride


subject: CHEBI:167204


subject: CHEBI:167204


subject: CHEBI:167204


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Adult Rhabdomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: alveolar rhabdomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: childhood pleomorphic rhabdomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:90942

subject_name: Ixazomib


subject: DRUGBANK:DB05361

object_name: venous thromboembolism


subject: DRUGBANK:DB05361

object_name: thrombophilia due to thrombin defect


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:94534

subject_name: olanzapine


subject: UMLS:C1445804

subject_name: pumpkin seed oil

object_name: hypertension


subject: UMLS:C1445804

object_name: Hypertension, CTCAE


subject: UMLS:C1445804

object_name: inherited lipid metabolism disorder


subject: UMLS:C1445804

object_name: Dyslipidemia


subject: CHEBI:64064

subject_name: Salmeterol

object_name: COPD, severe early onset


subject: CHEBI:64064

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:131954443

subject_name: Rovalpituzumab Tesirine

object_name: small cell lung carcinoma


subject: UNII:P256HB60FF


subject: UMLS:C3827079


subject: CHEBI:15361

subject_name: pyruvate

object_name: acute myocardial infarction


subject: CHEBI:15361

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:15361

object_name: heart failure


subject: CHEBI:15361

object_name: Heart Failure, CTCAE


subject: CHEBI:15361

object_name: cardiogenic shock


subject: MESH:D011773

subject_name: Pyruvates


subject: MESH:D011773


subject: MESH:D011773


subject: MESH:D011773


subject: MESH:D011773


subject: CHEBI:32816

subject_name: Pyruvic acid


subject: CHEBI:32816


subject: CHEBI:32816


subject: CHEBI:32816


subject: CHEBI:32816


subject: UNII:72W09924WP

subject_name: Asoprisnil

object_name: amenorrhea


subject: UNII:72W09924WP

object_name: Amenorrhea, CTCAE


subject: CHEBI:8389

subject_name: conjugated estrogens


subject: CHEBI:8389


subject: CHEBI:17474

subject_name: Estrone sulfate


subject: CHEBI:17474


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: PUBCHEM.COMPOUND:45357473


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:28748

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UMLS:C2605856

object_name: hepatitis C


subject: UMLS:C4721996

object_name: Malignant lymphoma of extranodal AND/OR solid organ site


subject: UMLS:C4721996

object_name: Childhood Solid Neoplasm


subject: UMLS:C4721996

object_name: Adult Solid Neoplasm


subject: UMLS:C4721996

object_name: Solid Neoplasm


subject: CHEBI:139072

object_name: Chronic cerebrovascular accident


subject: CHEBI:139072

object_name: stroke disorder


subject: CHEBI:139072

object_name: cerebrovascular disorder


subject: CHEBI:139072

object_name: Stroke (heart beat)


subject: CHEBI:139072

object_name: Stroke, CTCAE


subject: CHEBI:139072

object_name: Ischemic stroke


subject: CHEBI:139072

object_name: Hemiplegia and/or hemiparesis following stroke


subject: CHEBI:139072

object_name: middle cerebral artery infarction


subject: CHEBI:139072

object_name: intracerebral hemorrhage basal ganglia


subject: CHEBI:139072

object_name: Hemiplegia/hemiparesis


subject: CHEBI:139072

object_name: intracerebral hemorrhage


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: adult lymphoma


subject: UMLS:C0003442

object_name: lymphoma


subject: UMLS:C0003442

object_name: pediatric lymphoma


subject: UMLS:C0003442

object_name: leukemia


subject: UMLS:C0003442

object_name: childhood leukemia


subject: UMLS:C0003442


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888

object_name: Myelodysplasia


subject: CHEBI:6888


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat

object_name: hepatitis C


subject: RXCUI:659877

subject_name: Gardasil

object_name: uterine cervix neoplasm


subject: RXCUI:659877

object_name: cervical polyp


subject: RXCUI:659877

object_name: Cervical neoplasm


subject: RXCUI:659877

object_name: cervical intraepithelial neoplasia


subject: RXCUI:659877

object_name: dysplasia of cervix


subject: RXCUI:659877

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: UNII:7DP3NTV15T

subject_name: BLEOMYCIN SULFATE


subject: UNII:7DP3NTV15T


subject: UNII:7DP3NTV15T


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305


subject: CHEBI:4305


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:43996

subject_name: Mitoguazone


subject: CHEBI:43996


subject: CHEBI:43996


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:36373

subject_name: vindesine


subject: CHEBI:36373


subject: CHEBI:36373


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:3139

subject_name: bleomycin


subject: CHEBI:3139


subject: CHEBI:3139


subject: CHEBI:4875

subject_name: Etanercept

object_name: type 1 diabetes mellitus


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: Pregnant


subject: UNII:86EEZ49YVB

subject_name: FOSTAMATINIB DISODIUM

object_name: autoimmune thrombocytopenic purpura


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Inflammation


subject: CHEBI:39548

object_name: type 2 diabetes mellitus


subject: CHEBI:39548

object_name: Diabetes


subject: CHEBI:39548

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: PUBCHEM.COMPOUND:3062


subject: PUBCHEM.COMPOUND:3062


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: PUBCHEM.COMPOUND:3512

subject_name: Gris-PEG


subject: PUBCHEM.COMPOUND:3512


subject: PUBCHEM.COMPOUND:3512


subject: CHEBI:27779

subject_name: Griseofulvin


subject: CHEBI:27779


subject: CHEBI:27779


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:6503


subject: CHEBI:6503


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Pruritus, CTCAE


subject: CHEBI:74705

object_name: Pruritus


subject: CHEBI:74705

object_name: Vomiting, Postoperative


subject: CHEBI:74705

object_name: Postoperative Nausea


subject: CHEBI:74705

object_name: Post-Operative Pain


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Arthralgia


subject: CHEBI:3311

object_name: Arthralgia, CTCAE


subject: CHEBI:3311

object_name: Breast cancer stage II


subject: CHEBI:3311

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:3311

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: malignant neoplasm of breast stage I


subject: CHEBI:3311

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Carcinoma breast stage I


subject: CHEBI:3311

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:3311

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:3311

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:3311

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:3311

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:3311

object_name: Breast cancer recurrent


subject: CHEBI:3311

object_name: Musculoskeletal Complication


subject: PUBCHEM.COMPOUND:157010068

subject_name: Calcium citrate

object_name: Arthralgia


subject: PUBCHEM.COMPOUND:157010068

object_name: Arthralgia, CTCAE


subject: PUBCHEM.COMPOUND:157010068

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:157010068

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:157010068

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: malignant neoplasm of breast stage I


subject: PUBCHEM.COMPOUND:157010068

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Carcinoma breast stage I


subject: PUBCHEM.COMPOUND:157010068

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:157010068

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:157010068

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:157010068

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:157010068

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:157010068

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:157010068

object_name: Musculoskeletal Complication


subject: UNII:MLM29U2X85

object_name: Arthralgia


subject: UNII:MLM29U2X85

object_name: Arthralgia, CTCAE


subject: UNII:MLM29U2X85

object_name: Breast cancer stage II


subject: UNII:MLM29U2X85

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:MLM29U2X85

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: malignant neoplasm of breast stage I


subject: UNII:MLM29U2X85

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Carcinoma breast stage I


subject: UNII:MLM29U2X85

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Stage IIIA Breast Carcinoma


subject: UNII:MLM29U2X85

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:MLM29U2X85

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:MLM29U2X85

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Stage IIIB Breast Carcinoma


subject: UNII:MLM29U2X85

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:MLM29U2X85

object_name: Breast cancer recurrent


subject: UNII:MLM29U2X85

object_name: Musculoskeletal Complication


subject: CHEBI:16002

subject_name: Glucaric acid

object_name: Arthralgia


subject: CHEBI:16002

object_name: Arthralgia, CTCAE


subject: CHEBI:16002

object_name: Breast cancer stage II


subject: CHEBI:16002

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:16002

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: malignant neoplasm of breast stage I


subject: CHEBI:16002

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Carcinoma breast stage I


subject: CHEBI:16002

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:16002

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:16002

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:16002

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:16002

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:16002

object_name: Breast cancer recurrent


subject: CHEBI:16002

object_name: Musculoskeletal Complication


subject: UNII:SST07NLK7J

subject_name: Calcium saccharate

object_name: Arthralgia


subject: UNII:SST07NLK7J

object_name: Arthralgia, CTCAE


subject: UNII:SST07NLK7J

object_name: Breast cancer stage II


subject: UNII:SST07NLK7J

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:SST07NLK7J

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: malignant neoplasm of breast stage I


subject: UNII:SST07NLK7J

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Carcinoma breast stage I


subject: UNII:SST07NLK7J

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Stage IIIA Breast Carcinoma


subject: UNII:SST07NLK7J

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:SST07NLK7J

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:SST07NLK7J

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Stage IIIB Breast Carcinoma


subject: UNII:SST07NLK7J

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:SST07NLK7J

object_name: Breast cancer recurrent


subject: UNII:SST07NLK7J

object_name: Musculoskeletal Complication


subject: UMLS:C0006698

subject_name: calcium glucarate

object_name: Arthralgia


subject: UMLS:C0006698

object_name: Arthralgia, CTCAE


subject: UMLS:C0006698

object_name: Breast cancer stage II


subject: UMLS:C0006698

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C0006698

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: malignant neoplasm of breast stage I


subject: UMLS:C0006698

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Carcinoma breast stage I


subject: UMLS:C0006698

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0006698

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C0006698

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0006698

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0006698

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C0006698

object_name: Breast cancer recurrent


subject: UMLS:C0006698

object_name: Musculoskeletal Complication


subject: PUBCHEM.COMPOUND:6095520

object_name: Arthralgia


subject: PUBCHEM.COMPOUND:6095520

object_name: Arthralgia, CTCAE


subject: PUBCHEM.COMPOUND:6095520

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:6095520

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:6095520

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: malignant neoplasm of breast stage I


subject: PUBCHEM.COMPOUND:6095520

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Carcinoma breast stage I


subject: PUBCHEM.COMPOUND:6095520

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:6095520

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:6095520

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:6095520

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:6095520

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:6095520

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:6095520

object_name: Musculoskeletal Complication


subject: PUBCHEM.COMPOUND:89465

subject_name: Glucal

object_name: Arthralgia


subject: PUBCHEM.COMPOUND:89465

object_name: Arthralgia, CTCAE


subject: PUBCHEM.COMPOUND:89465

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:89465

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:89465

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: malignant neoplasm of breast stage I


subject: PUBCHEM.COMPOUND:89465

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Carcinoma breast stage I


subject: PUBCHEM.COMPOUND:89465

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:89465

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:89465

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:89465

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:89465

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:89465

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:89465

object_name: Musculoskeletal Complication


subject: CHEBI:3309

subject_name: Calcium gluconate

object_name: Arthralgia


subject: CHEBI:3309

object_name: Arthralgia, CTCAE


subject: CHEBI:3309

object_name: Breast cancer stage II


subject: CHEBI:3309

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:3309

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: malignant neoplasm of breast stage I


subject: CHEBI:3309

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Carcinoma breast stage I


subject: CHEBI:3309

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:3309

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:3309

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:3309

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:3309

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:3309

object_name: Breast cancer recurrent


subject: CHEBI:3309

object_name: Musculoskeletal Complication


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Arthralgia


subject: UNII:1C6V77QF41

object_name: Arthralgia, CTCAE


subject: UNII:1C6V77QF41

object_name: Breast cancer stage II


subject: UNII:1C6V77QF41

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:1C6V77QF41

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: malignant neoplasm of breast stage I


subject: UNII:1C6V77QF41

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Carcinoma breast stage I


subject: UNII:1C6V77QF41

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Stage IIIA Breast Carcinoma


subject: UNII:1C6V77QF41

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:1C6V77QF41

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:1C6V77QF41

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Stage IIIB Breast Carcinoma


subject: UNII:1C6V77QF41

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:1C6V77QF41

object_name: Breast cancer recurrent


subject: UNII:1C6V77QF41

object_name: Musculoskeletal Complication


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: Arthralgia


subject: CHEBI:27300

object_name: Arthralgia, CTCAE


subject: CHEBI:27300

object_name: Breast cancer stage II


subject: CHEBI:27300

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:27300

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: malignant neoplasm of breast stage I


subject: CHEBI:27300

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Carcinoma breast stage I


subject: CHEBI:27300

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:27300

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:27300

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:27300

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:27300

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:27300

object_name: Breast cancer recurrent


subject: CHEBI:27300

object_name: Musculoskeletal Complication


subject: CHEBI:6413

subject_name: Letrozole

object_name: Arthralgia


subject: CHEBI:6413

object_name: Arthralgia, CTCAE


subject: CHEBI:6413

object_name: Breast cancer stage II


subject: CHEBI:6413

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:6413

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: malignant neoplasm of breast stage I


subject: CHEBI:6413

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Carcinoma breast stage I


subject: CHEBI:6413

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:6413

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:6413

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:6413

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:6413

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:6413

object_name: Breast cancer recurrent


subject: CHEBI:6413

object_name: Musculoskeletal Complication


subject: UMLS:C3490349

object_name: type 2 diabetes mellitus


subject: UNII:WBH8AY6ENB

subject_name: Lerociclib

object_name: Advanced breast cancer


subject: CHEBI:6413


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Complications of bone marrow transplant


subject: CHEBI:4026

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:4026

object_name: Engraft failure


subject: CHEBI:4026

object_name: viral disease


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:177298

object_name: Metastatic Castration-Sensitive Prostate Carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:80555

subject_name: ENDOXIFEN

object_name: Breast Density


subject: UMLS:C0957573


subject: CHEBI:83766

subject_name: Olaparib

object_name: prostate carcinoma


subject: CHEBI:83766

object_name: prostate cancer


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0000392

subject_name: beta-alanine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: age-related macular degeneration


subject: UNII:2S9ZZM9Q9V

object_name: wet macular degeneration


subject: UNII:2S9ZZM9Q9V

object_name: Branch retinal vein occlusion


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: diabetic kidney disease


subject: CHEBI:27812

object_name: chronic kidney disease


subject: CHEBI:27812

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:27812

object_name: kidney failure


subject: CHEBI:27812

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: CHEBI:27812

object_name: type 2 diabetes mellitus


subject: CHEBI:27812

object_name: type 1 diabetes mellitus 1


subject: CHEBI:27812

object_name: type 1 diabetes mellitus


subject: CHEBI:94534

subject_name: olanzapine

object_name: treatment resistant depression


subject: CHEBI:94534


subject: CHEBI:50386

subject_name: cysteamine bitartrate

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:50386

object_name: mitochondrial disease


subject: CHEBI:17141

subject_name: Cysteamine


subject: CHEBI:17141


subject: CHEBI:229652

subject_name: Iptacopan

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C0123677

subject_name: NovoLog


subject: UMLS:C5666907

subject_name: Anti-TIGIT Bispecific Antibody AGEN1777

object_name: Advanced cancer


subject: CHEBI:135552

subject_name: Prucalopride

object_name: Constipation


subject: CHEBI:135552

object_name: Constipation, CTCAE


subject: UMLS:C2987428

subject_name: rontalizumab

object_name: EXCESS LMW-DNA


subject: CHEBI:2704

subject_name: Anastrozole

object_name: hypopituitarism


subject: CHEBI:2704

object_name: Hypopituitarism, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: plasmablastic lymphoma


subject: CHEBI:4026

object_name: large-cell immunoblastic lymphoma


subject: CHEBI:4026

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:4026

object_name: MYC Gene Mutation


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942

object_name: diffuse large B-cell lymphoma


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C4552074

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C4552074

object_name: Childhood Hematopoietic and Lymphoid Cell Neoplasm


subject: UMLS:C4552074

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:91408

subject_name: Fedratinib


subject: CHEBI:91408


subject: CHEBI:91408


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: inflammatory spondylopathy


subject: UNII:FYS6T7F842

object_name: spondyloarthropathy


subject: CHEBI:4875

subject_name: Etanercept


subject: CHEBI:4875


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: UNII:91X1KLU43E

subject_name: Golimumab


subject: UNII:91X1KLU43E


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: UNII:B72HH48FLU


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: non-small cell lung carcinoma


subject: CHEBI:93786


subject: CHEBI:93786

object_name: Effects of chemotherapy


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Neck Carcinoma


subject: CHEBI:17061

object_name: head and neck neoplasm


subject: CHEBI:17061

object_name: head and neck cancer


subject: CHEBI:17061

object_name: mucositis


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Nausea, CTCAE_5


subject: CHEBI:6456

object_name: Nausea


subject: CHEBI:6456

object_name: Nausea, CTCAE_3


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:60802


subject: RXCUI:659877

subject_name: Gardasil

object_name: HIV infection


subject: RXCUI:659877

object_name: anus cancer


subject: RXCUI:659877

object_name: anal carcinoma


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Childhood Solid Neoplasm


subject: CHEBI:233362

object_name: Adult Solid Neoplasm


subject: CHEBI:233362

object_name: Solid Neoplasm


subject: CHEBI:233362

object_name: colon carcinoma


subject: CHEBI:233362

object_name: colorectal cancer


subject: CHEBI:233362

object_name: colon cancer


subject: CHEBI:233362

object_name: Childhood Breast Carcinoma


subject: CHEBI:233362

object_name: breast carcinoma


subject: CHEBI:233362

object_name: breast cancer


subject: CHEBI:233362

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:233362

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:233362

object_name: sarcoma


subject: CHEBI:233362

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:233362

object_name: soft tissue sarcoma


subject: CHEBI:233362

object_name: cholangiocarcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: UNII:C88817F47Y


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: CHEBI:232469


subject: UNII:QY8BWX1LJ5

subject_name: Taladegib


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UNII:QY8BWX1LJ5


subject: UMLS:C2987686

subject_name: Sodium Bicarbonate Solution


subject: UMLS:C2987686

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C2987686

object_name: Acute respiratory distress syndrome due to COVID-19


subject: CHEBI:17688

subject_name: Nicotine

object_name: schizophrenia


subject: UNII:7V6HE3DM5A

subject_name: Ocriplasmin

object_name: Vitreomacular traction


subject: UNII:7V6HE3DM5A

object_name: Vitreomacular adhesion


subject: CHEBI:15365

subject_name: Aspirin

object_name: arteriosclerosis disorder


subject: CHEBI:15365

object_name: atherosclerosis


subject: CHEBI:15365

object_name: cardiovascular disorder


subject: CHEBI:15365

object_name: myocardial infarction


subject: CHEBI:15365

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:15365

object_name: Myocardial Infarction by ECG Finding


subject: PUBCHEM.COMPOUND:77014446

subject_name: Ketofol

object_name: sleep apnea


subject: PUBCHEM.COMPOUND:77014446

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:77014446

object_name: obesity


subject: PUBCHEM.COMPOUND:77014446

object_name: Obesity, CTCAE


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:9758

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: GTOPDB:9758

object_name: malignant tumor of nasopharynx


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C5203179

subject_name: Adalimumab Liquid Injection

object_name: Takayasu arteritis


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: CHEBI:3441

subject_name: Carvedilol

object_name: esophageal varices


subject: CHEBI:3441

object_name: portal hypertension


subject: CHEBI:3441

object_name: Portal Hypertension, CTCAE


subject: CHEBI:3441

object_name: Bleeding varices


subject: CHEBI:3441

object_name: liver cirrhosis


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:134506

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:134506

object_name: breast cancer


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: skin squamous cell carcinoma


subject: UNII:6QVL057INT

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4733632

subject_name: Clostridium butyricum CBM 588 Probiotic Strain

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C4733632

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C4733632

object_name: Advanced renal cell carcinoma


subject: UMLS:C4733632

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4733632

object_name: clear cell renal carcinoma


subject: UMLS:C4733632

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C4733632

object_name: Unresectable Renal Cell Carcinoma


subject: UMLS:C4733632

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: Metastatic Cutaneous Melanoma


subject: UNII:25E79B5CTM

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:25E79B5CTM

object_name: metastatic melanoma


subject: UNII:25E79B5CTM

object_name: stage IIIC melanoma


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: UMLS:C0211023


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Malignant neoplasm of abdomen


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Disorder due to radiotherapy


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Protein Deficiency


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Weight loss


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Weight Loss, CTCAE


subject: PUBCHEM.COMPOUND:56841660

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:56841660

object_name: prostate cancer


subject: UNII:IC5V8479H3


subject: UNII:IC5V8479H3


subject: UMLS:C0935832

subject_name: MUC-2-Globo H-KLH Conjugate Vaccine


subject: UMLS:C0935832


subject: PUBCHEM.COMPOUND:6367079

subject_name: Nepicastat

object_name: post-traumatic stress disorder


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stomach cancer


subject: CHEBI:31348

object_name: gastric cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:134506

object_name: substance withdrawal syndrome


subject: CHEBI:28689


subject: CHEBI:85252


subject: CHEBI:89608


subject: CHEBI:16581

subject_name: Pregnenolone


subject: UNII:N24015WC6D

subject_name: Atevirdine

object_name: HIV-1 infection


subject: CHEBI:37924

subject_name: Atazanavir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:31781

subject_name: Lopinavir


subject: UMLS:C3537103

subject_name: Nucleoside Reverse Transcriptase Inhibitor


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:90001


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: CHEBI:58097

object_name: childhood malignant neoplasm


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:71219

subject_name: Pazopanib

object_name: germ cell tumor


subject: CHEBI:71219

object_name: Measurable Disease


subject: UMLS:C5417813

subject_name: Fc-engineered Anti-CD40 Agonist Antibody 2141-V11

object_name: cancer


subject: UMLS:C5417813

object_name: neoplasm


subject: UMLS:C5417813

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417813

object_name: Adult Solid Neoplasm


subject: UMLS:C5417813

object_name: Solid Neoplasm


subject: UMLS:C5417813

object_name: skin cancer


subject: CHEBI:90922

subject_name: Genvoya

object_name: HIV infection


subject: PUBCHEM.COMPOUND:12043008

subject_name: Stribild


subject: UMLS:C3275286

object_name: adult acute myeloid leukemia


subject: UMLS:C3275286

object_name: childhood acute myeloid leukemia


subject: UMLS:C3275286

object_name: acute myeloid leukemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: liver carcinoma


subject: UMLS:C2346820


subject: UMLS:C4733483

subject_name: radiopharmaceutical BAY1862864

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4733483

object_name: non-Hodgkin lymphoma


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: nephrotic syndrome


subject: CHEBI:168396

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:4953

subject_name: Exemestane

object_name: Breast cancer stage II


subject: CHEBI:4953

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:4953

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:4953

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:4953

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:4953

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:4953

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Refractory Head and Neck Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:PQX0D8J21J

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UNII:PQX0D8J21J

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:PQX0D8J21J

object_name: Refractory Laryngeal Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Refractory Oral Cavity Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: Refractory Oropharyngeal Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UNII:PQX0D8J21J

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:PQX0D8J21J

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:PQX0D8J21J

object_name: Refractory Hypopharyngeal Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C0879636

subject_name: IMC C225

object_name: Refractory Head and Neck Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Recurrent Neck Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C0879636

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UMLS:C0879636

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C0879636

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C0879636

object_name: Refractory Laryngeal Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Refractory Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0879636

object_name: Refractory Oropharyngeal Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C0879636

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C0879636

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C0879636

object_name: Refractory Hypopharyngeal Squamous Cell Carcinoma


subject: UMLS:C0879636

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C0879636

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C0879636

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:174615

object_name: acute myeloid leukemia


subject: CHEBI:28901

subject_name: Busulfan


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UMLS:C5226733

object_name: Pemphigoid


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Advanced Melanoma


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: pediatric osteosarcoma


subject: UNII:GKF8S4C432

object_name: Osteosarcoma


subject: CHEBI:9139

subject_name: Sildenafil

object_name: perinatal asphyxia


subject: CHEBI:9139

object_name: instrumental delivery; affecting fetus


subject: CHEBI:9139

object_name: intrapartum foetal distress


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Gambling


subject: UMLS:C5237476

subject_name: Rescue Medications

object_name: gastroesophageal adenocarcinoma


subject: UMLS:C5237476

object_name: carcinoma of esophagus


subject: UMLS:C5237476

object_name: esophageal cancer


subject: UMLS:C5237476

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5237476

object_name: neoplasm of esophagus


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: GTOPDB:13791


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UNII:3DV5TD1VL3


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C5237963


subject: UMLS:C2698296

subject_name: Hyperacute Melanoma

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C2698296

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2698296

object_name: metastatic melanoma


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]


subject: UMLS:C5848866


subject: UMLS:C5848866


subject: UNII:VI6E2D3CYP

object_name: Childhood Solid Neoplasm


subject: UNII:VI6E2D3CYP

object_name: Adult Solid Neoplasm


subject: UNII:VI6E2D3CYP

object_name: Solid Neoplasm


subject: UMLS:C5206611

subject_name: Glucocorticoid Receptor Antagonist ORIC-101


subject: UMLS:C5206611


subject: UMLS:C5206611


subject: CHEMBL.COMPOUND:CHEMBL4802177


subject: CHEMBL.COMPOUND:CHEMBL4802177


subject: CHEMBL.COMPOUND:CHEMBL4802177


subject: CHEBI:45267

subject_name: praziquantel

object_name: hydronephrosis


subject: CHEBI:45267

object_name: Hematuria, CTCAE


subject: CHEBI:45267

object_name: Hematuria


subject: CHEBI:91583

subject_name: Praziquantel


subject: CHEBI:91583


subject: CHEBI:91583


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: cancer


subject: UMLS:C0770246

object_name: neoplasm


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Myocardial Reperfusion Injury


subject: CHEBI:132922

object_name: toothache


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Neck Carcinoma


subject: CHEBI:52717

object_name: head and neck neoplasm


subject: CHEBI:52717

object_name: head and neck cancer


subject: CHEBI:52717

object_name: central nervous system cancer


subject: CHEBI:52717

object_name: brain cancer


subject: CHEBI:52717

object_name: brain neoplasm


subject: CHEBI:52717

object_name: cervical cancer


subject: CHEBI:52717

object_name: cervical carcinoma


subject: CHEBI:94366

subject_name: itraconazole

object_name: sinusitis


subject: CHEBI:94366

object_name: Sinusitis, CTCAE


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: acute kidney failure


subject: UMLS:C0013227

object_name: acute renal disease


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: CHEBI:133246

subject_name: Ligustrazine


subject: CHEBI:133246


subject: CHEBI:45394

subject_name: TMP


subject: CHEBI:45394


subject: CHEBI:46324

subject_name: trimethyl phosphate


subject: CHEBI:46324


subject: CHEBI:9533

subject_name: thiamine(1+) monophosphate


subject: CHEBI:9533


subject: CHEBI:17013

subject_name: dTMP


subject: CHEBI:17013


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: UMLS:C0384479

subject_name: epithelial membrane protein-1


subject: UMLS:C0384479


subject: PR:000007062

subject_name: epithelial membrane protein 1


subject: PR:000007062


subject: UniProtKB:P36590

subject_name: KTHY_SCHPO Thymidylate kinase (sprot)


subject: UniProtKB:P36590


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Childhood Breast Carcinoma


subject: CHEBI:5790

object_name: breast carcinoma


subject: CHEBI:5790

object_name: breast cancer


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: male breast carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: mantle cell lymphoma


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: UMLS:C1699394

subject_name: Hylenex


subject: UNII:9J13XU96Z1

subject_name: Azenosertib

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Resectable Pancreatic Ductal Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Unresectable Pancreatic Ductal Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: UNII:9J13XU96Z1

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:9J13XU96Z1

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:9J13XU96Z1

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: UNII:67RM91WDHQ

subject_name: Onvansertib


subject: UNII:67RM91WDHQ


subject: UNII:67RM91WDHQ


subject: UNII:67RM91WDHQ


subject: UNII:67RM91WDHQ


subject: UNII:67RM91WDHQ


subject: UNII:67RM91WDHQ


subject: UNII:67RM91WDHQ


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: DRUGBANK:DB18982

subject_name: Saruparib


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: PUBCHEM.COMPOUND:139331475

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:139331475

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: Solid Neoplasm


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: PUBCHEM.COMPOUND:134540598

subject_name: ICALCAPRANT

object_name: bipolar II disorder


subject: PUBCHEM.COMPOUND:134540598

object_name: bipolar I disorder


subject: UNII:GNR4JZG668


subject: UNII:GNR4JZG668


subject: UMLS:C5909102

subject_name: Icalcaprant


subject: UMLS:C5909102


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: PUBCHEM.COMPOUND:3368

object_name: Miller-Dieker lissencephaly syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: myoclonic dystonia 11


subject: PUBCHEM.COMPOUND:3368

object_name: chronic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: pediatric lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: UMLS:C2347401

subject_name: Oral Microencapsulated Diindolylmethane

object_name: prostate carcinoma


subject: UMLS:C2347401

object_name: prostate cancer


subject: CHEBI:6121

subject_name: Ketamine

object_name: Idiopathic scoliosis and kyphoscoliosis


subject: CHEBI:6121

object_name: idiopathic scoliosis


subject: CHEBI:6121

object_name: spondylolisthesis


subject: CHEBI:6121

object_name: Congenital spondylolisthesis


subject: CHEBI:6121

object_name: Acquired spondylolisthesis


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:104747

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:104747

object_name: breast cancer


subject: CHEBI:17568

subject_name: Uracil


subject: CHEBI:17568


subject: CHEBI:17568


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:32188


subject: CHEBI:32188


subject: PUBCHEM.COMPOUND:121428882


subject: UNII:7716RH2FJT


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:28593

subject_name: Quinidine


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: atrial fibrillation


subject: CHEBI:4466

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:4466

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:4466

object_name: Sedation


subject: CHEBI:4466

object_name: Sedated


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: peritoneum cancer


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: fallopian tube carcinoma


subject: CHEBI:175901

object_name: fallopian tube cancer


subject: CHEBI:175901


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748

object_name: malignant epithelial tumor of ovary


subject: CHEBI:28748

object_name: Childhood Solid Neoplasm


subject: CHEBI:28748

object_name: Adult Solid Neoplasm


subject: CHEBI:28748

object_name: Solid Neoplasm


subject: UMLS:C5238233

subject_name: Wee1 Inhibitor ZN-c3


subject: UMLS:C5238233


subject: UMLS:C5238233


subject: UMLS:C5238233

object_name: ovarian carcinoma


subject: UMLS:C5238233


subject: UMLS:C5238233


subject: UMLS:C5238233


subject: UMLS:C5238233


subject: CHEBI:91432

subject_name: Brivanib

object_name: liver cancer


subject: CHEBI:91432

object_name: liver neoplasm


subject: CHEBI:91432

object_name: Adult Liver Carcinoma


subject: CHEBI:91432

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:71364

subject_name: icatibant

object_name: angioedema


subject: UMLS:C5814684

object_name: mucopolysaccharidosis type 3A


subject: UMLS:C5814684

object_name: mucopolysaccharidosis type 3


subject: DRUGBANK:DB16784

subject_name: Rebisufligene etisparvovec


subject: DRUGBANK:DB16784


subject: UMLS:C4085973

object_name: triple-negative breast carcinoma


subject: UMLS:C4085973

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4085973

object_name: hormone receptor-positive breast cancer


subject: UMLS:C4085973

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UMLS:C4085973

object_name: HER2-Low Breast Carcinoma


subject: CHEBI:2639

subject_name: Amiloride


subject: CHEBI:2639


subject: CHEBI:2639


subject: CHEBI:2639


subject: CHEBI:2639


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: osteoporosis


subject: UNII:4988K7X26P

object_name: Encounter due to family history of osteoporosis


subject: UNII:4988K7X26P

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:4988K7X26P

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:135935

subject_name: Tapentadol

object_name: Hallux valgus


subject: CHEBI:134745

subject_name: Glycerol phenylbutyrate

object_name: progressive familial intrahepatic cholestasis


subject: CHEBI:134745

object_name: progressive familial intrahepatic cholestasis type 1


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: medullary thyroid gland carcinoma


subject: UMLS:C1710686


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: biliary tract cancer


subject: CHEBI:4466

object_name: Surgical procedure finding


subject: CHEBI:4466

object_name: Anesthesia morbidity


subject: CHEBI:4466

object_name: Complication of anesthesia


subject: CHEBI:4466

object_name: outcomes general quality of life


subject: CHEBI:4466

object_name: Perceived quality of life


subject: CHEBI:4466

object_name: Good quality of life


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: UMLS:C0062525

subject_name: Hyperhep B

object_name: hepatitis B


subject: CHEMBL.COMPOUND:CHEMBL2108512

subject_name: HEPATITIS B IMMUNE GLOBULIN


subject: CHEBI:3095

subject_name: Biguanide


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Viral gastroenteritis due to Rotavirus


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: hypotrichosis


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: Extravasation of Diagnostic and Therapeutic Materials


subject: CHEBI:50223

object_name: Extravasation


subject: CHEBI:66910

subject_name: Axitinib

object_name: colorectal cancer


subject: CHEBI:66910

object_name: colorectal carcinoma


subject: CHEBI:66910

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000015526

subject_name: transcription factor Spi-C

object_name: Anterior Cruciate Ligament Injuries


subject: PR:000015526

object_name: Sensory Disorders


subject: PR:000015526

object_name: Knee Injuries


subject: UMLS:C0033374

subject_name: Prolactin-Releasing Hormone


subject: UMLS:C0033374


subject: UMLS:C0033374


subject: CHEBI:231683

subject_name: Anakinra

object_name: temporal arteritis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: triple-negative breast carcinoma


subject: UNII:52CMI0WC3Y

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:52CMI0WC3Y

object_name: bladder tumor


subject: UNII:52CMI0WC3Y

object_name: urinary bladder carcinoma


subject: UNII:52CMI0WC3Y

object_name: urinary bladder cancer


subject: UNII:52CMI0WC3Y

object_name: childhood bladder carcinoma


subject: UNII:52CMI0WC3Y

object_name: renal carcinoma


subject: UNII:52CMI0WC3Y

object_name: kidney cancer


subject: UNII:52CMI0WC3Y

object_name: melanoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEMBL.COMPOUND:CHEMBL4650376

subject_name: AUTOGENE CEVUMERAN

object_name: Neck Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650376

object_name: head and neck neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650376

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650376

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4650376

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4650376

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: CHEMBL.COMPOUND:CHEMBL4650376


subject: UMLS:C4705457

object_name: rheumatoid arthritis


subject: CHEBI:5558

subject_name: Guanfacine

object_name: Tourette syndrome


subject: CHEBI:3757

subject_name: Clonidine

object_name: Treatment related secondary malignancy


subject: CHEBI:90687

object_name: Childhood Breast Carcinoma


subject: CHEBI:90687

object_name: breast carcinoma


subject: CHEBI:90687

object_name: breast cancer


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: benign prostatic hyperplasia


subject: CHEBI:177703

subject_name: Latanoprostene bunod

object_name: glaucoma


subject: CHEBI:177703

object_name: Glaucoma, CTCAE


subject: CHEBI:177703

object_name: ocular hypertension


subject: CHEBI:177703

object_name: Ocular hypertension


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: Cryptococcal meningitis


subject: UMLS:C1831781

subject_name: Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine


subject: UMLS:C1831781


subject: UMLS:C1831781


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib


subject: CHEBI:518413

subject_name: Alverine

object_name: portal hypertension


subject: UNII:D42O649ALL

subject_name: Telcagepant

object_name: coronary artery disorder


subject: UNII:D42O649ALL

object_name: Angina pectoris


subject: UMLS:C1710703

subject_name: Yttrium Y-90-DOTA-Girentuximab

object_name: renal carcinoma


subject: UMLS:C1710703

object_name: kidney cancer


subject: UMLS:C1710703

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C1710703

object_name: clear cell renal carcinoma


subject: UMLS:C1710703

object_name: renal cell adenocarcinoma


subject: UMLS:C1710703

object_name: renal cell carcinoma


subject: UMLS:C1710703

object_name: kidney neoplasm


subject: UMLS:C1710703

object_name: childhood kidney neoplasm


subject: UNII:995FT1W541

subject_name: Idronoxil

object_name: ovarian cancer


subject: UNII:995FT1W541

object_name: ovarian neoplasm


subject: UNII:995FT1W541

object_name: ovarian carcinoma


subject: UNII:995FT1W541

object_name: fallopian tube carcinoma


subject: UNII:995FT1W541

object_name: fallopian tube cancer


subject: UNII:995FT1W541

object_name: peritoneal neoplasm


subject: GTOPDB:9219

object_name: wet macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL4594457


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Wet age-related macular degeneration


subject: UNII:ZL1R02VT79

object_name: Choroidal retinal neovascularization


subject: UNII:ZL1R02VT79

object_name: choroidal neovascularization


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: bipolar disorder


subject: MESH:C561371

object_name: rheumatoid arthritis


subject: CHEBI:499361

subject_name: Aprepitant

object_name: gestational trophoblastic neoplasm


subject: CHEBI:499361

object_name: testicular germ cell tumor 1


subject: CHEBI:499361

object_name: testicular germ cell tumor


subject: CHEBI:499361

object_name: childhood testicular germ cell tumor


subject: CHEBI:499361


subject: CHEBI:499361


subject: CHEBI:499361


subject: CHEBI:499361


subject: CHEBI:499361

object_name: Childhood Breast Carcinoma


subject: CHEBI:499361

object_name: breast carcinoma


subject: CHEBI:499361

object_name: breast cancer


subject: CHEBI:499361

object_name: Childhood Neuroblastoma


subject: CHEBI:499361

object_name: neuroblastoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Nausea and vomiting


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879

object_name: myeloproliferative neoplasm


subject: CHEBI:41879

object_name: Myelodysplasia


subject: CHEBI:41879

object_name: ovarian cancer


subject: CHEBI:41879

object_name: ovarian neoplasm


subject: CHEBI:41879

object_name: ovarian carcinoma


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:5538

subject_name: Granisetron hydrochloride


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538


subject: CHEBI:5538

object_name: adult lymphoma


subject: CHEBI:5538

object_name: lymphoma


subject: CHEBI:5538

object_name: pediatric lymphoma


subject: CHEBI:5538

object_name: leukemia


subject: CHEBI:5538

object_name: childhood leukemia


subject: CHEBI:184693

subject_name: GRANISETRON


subject: CHEBI:184693

object_name: gestational trophoblastic neoplasm


subject: CHEBI:184693

object_name: testicular germ cell tumor 1


subject: CHEBI:184693

object_name: testicular germ cell tumor


subject: CHEBI:184693

object_name: childhood testicular germ cell tumor


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693

object_name: Childhood Breast Carcinoma


subject: CHEBI:184693

object_name: breast carcinoma


subject: CHEBI:184693

object_name: breast cancer


subject: CHEBI:184693

object_name: Childhood Neuroblastoma


subject: CHEBI:184693

object_name: neuroblastoma


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693


subject: CHEBI:184693


subject: UNII:318F6L70J8

subject_name: GRANISETRON HYDROCHLORIDE

object_name: Nausea and vomiting


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8

object_name: myeloproliferative neoplasm


subject: UNII:318F6L70J8

object_name: Myelodysplasia


subject: UNII:318F6L70J8

object_name: ovarian cancer


subject: UNII:318F6L70J8

object_name: ovarian neoplasm


subject: UNII:318F6L70J8

object_name: ovarian carcinoma


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8


subject: UNII:318F6L70J8

object_name: adult lymphoma


subject: UNII:318F6L70J8

object_name: lymphoma


subject: UNII:318F6L70J8

object_name: pediatric lymphoma


subject: UNII:318F6L70J8

object_name: leukemia


subject: UNII:318F6L70J8

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:155543961

object_name: coronary atherosclerosis


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: glioblastoma


subject: UNII:TWF0ML1CK8

object_name: Childhood Glioblastoma


subject: UNII:TWF0ML1CK8

object_name: adult glioblastoma


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Transfusion dependent thalassaemia


subject: UMLS:C4684893

subject_name: Anti-HER2 Monoclonal Antibody/Anti-CD137 Anticalin Bispecific Fusion Protein PRS-343

object_name: HER2 positive breast carcinoma


subject: UMLS:C4684893

object_name: HER2 positive bladder cancer


subject: UMLS:C4684893

object_name: HER2-positive gastric cancer


subject: CHEBI:44915

subject_name: Propofol

object_name: adverse effect


subject: CHEBI:44915

object_name: Adverse effects


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: prostate carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Emergence Delirium


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: delirium


subject: PUBCHEM.COMPOUND:54675783

object_name: Delirium, CTCAE


subject: PUBCHEM.COMPOUND:54675783

object_name: ocular motor apraxia, Cogan type


subject: UMLS:C4287800

subject_name: Defactinib Hydrochloride

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C4287800

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C4287800

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4287800

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C4287800

object_name: Plasma cell myeloma refractory


subject: UMLS:C4287800

object_name: Advanced Lymphoma


subject: UMLS:C4287800

object_name: Refractory Lymphoma


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: CHEBI:74705

subject_name: Met-Leu

object_name: type 1 diabetes mellitus 1


subject: CHEBI:74705

object_name: type 1 diabetes mellitus


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:6931

subject_name: Midazolam

object_name: pain agnosia


subject: CHEBI:6931

object_name: Pain insensitivity


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Surgical procedure finding


subject: UMLS:C2348288

object_name: malnutrition


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:91899

object_name: COPD, severe early onset


subject: CHEBI:3207

subject_name: Budesonide


subject: UNII:A14FB57V1D

subject_name: GLYCOPYRRONIUM


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: UMLS:C0003374

subject_name: Antimalarials

object_name: EXCESS LMW-DNA


subject: UMLS:C3536844

subject_name: Antimalarial [EPC]


subject: CHEBI:50730

subject_name: Montelukast

object_name: atopic eczema


subject: UMLS:C0392938

subject_name: zoledronate

object_name: osteoporosis


subject: UMLS:C0392938

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C0392938

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C0392938

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Diabetes


subject: PUBCHEM.COMPOUND:73151030

object_name: diabetes mellitus


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: type 2 diabetes mellitus


subject: UMLS:C3714501


subject: UMLS:C3714501


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Cooley's anemia


subject: PUBCHEM.COMPOUND:2735

object_name: beta thalassemia


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: cholangiocarcinoma


subject: MESH:C520255

object_name: biliary tract cancer


subject: MESH:C520255

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: gallbladder cancer


subject: MESH:C520255

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: Stage III Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: gallbladder carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Anesthetics adverse reaction


subject: CHEBI:26710

subject_name: Sodium chloride


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IV Prostate Cancer AJCC v6


subject: UNII:2S9ZZM9Q9V

object_name: Carcinoma of the prostate stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Prostate cancer recurrent


subject: UNII:2S9ZZM9Q9V

object_name: hormone-resistant prostate carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: prostate adenocarcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:31562

subject_name: estramustine sodium phosphate


subject: CHEBI:31562


subject: CHEBI:31562


subject: CHEBI:31562


subject: CHEBI:31562


subject: CHEBI:31562


subject: CHEBI:31562


subject: UNII:75F375MT2N

subject_name: Estramustine Phosphate Sodium Hydrate


subject: UNII:75F375MT2N


subject: UNII:75F375MT2N


subject: UNII:75F375MT2N


subject: UNII:75F375MT2N


subject: UNII:75F375MT2N


subject: UNII:75F375MT2N


subject: PUBCHEM.COMPOUND:18140


subject: PUBCHEM.COMPOUND:18140


subject: PUBCHEM.COMPOUND:18140


subject: PUBCHEM.COMPOUND:18140


subject: PUBCHEM.COMPOUND:18140


subject: PUBCHEM.COMPOUND:18140


subject: PUBCHEM.COMPOUND:18140


subject: CHEBI:4868

subject_name: Estramustine


subject: CHEBI:4868


subject: CHEBI:4868


subject: CHEBI:4868


subject: CHEBI:4868


subject: CHEBI:4868


subject: CHEBI:4868


subject: PUBCHEM.COMPOUND:73897520

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:73897520

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:73897520

object_name: type 1 diabetes mellitus


subject: UNII:726I6TE06G

subject_name: PRAMLINTIDE ACETATE


subject: UNII:726I6TE06G


subject: UNII:726I6TE06G


subject: UMLS:C1174779

subject_name: Symlin


subject: UMLS:C1174779


subject: UMLS:C1174779


subject: PUBCHEM.COMPOUND:139600705

subject_name: Pramlintide


subject: PUBCHEM.COMPOUND:139600705


subject: PUBCHEM.COMPOUND:139600705


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Stevens-Johnson syndrome


subject: UNII:B72HH48FLU

object_name: Stevens-Johnson Syndrome, CTCAE


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: GTOPDB:9758

object_name: Carcinoma breast stage IV


subject: GTOPDB:9758

object_name: malignant neoplasm of breast stage IV


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid


subject: CHEBI:231005


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: Iron deficiency


subject: UNII:Q91187K011

object_name: iron deficiency anemia


subject: CHEBI:144421

subject_name: ferric citrate


subject: CHEBI:144421


subject: UMLS:C1563959

subject_name: Ebixa

object_name: Alzheimer disease


subject: UMLS:C1563959

object_name: Presenile dementia


subject: UMLS:C1563959

object_name: dementia


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:64312


subject: UMLS:C0086555

subject_name: licorice

object_name: lichen planus, oral


subject: UMLS:C0770612

subject_name: licorice root extract


subject: UMLS:C2728191

subject_name: Licorice


subject: UMLS:C3274916

subject_name: GRASPA

object_name: pancreatic adenocarcinoma


subject: GTOPDB:13330

subject_name: prasinezumab

object_name: Parkinson disease


subject: CHEMBL.COMPOUND:CHEMBL4298077

subject_name: PRASINEZUMAB


subject: UMLS:C5139914

subject_name: Prasinezumab


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Cannabis use disorder


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: graft versus host disease


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: Non-small cell lung cancer stage III


subject: UNII:T4RS462G19

object_name: Activating EGFR Gene Mutation


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: Duchenne muscular dystrophy


subject: UNII:8D3PZX7G73

object_name: Sicca Syndrome


subject: UNII:8D3PZX7G73

object_name: Xerostomia


subject: PUBCHEM.COMPOUND:3222

object_name: essential hypertension


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:135930

subject_name: Lercanidipine


subject: CHEBI:94708

subject_name: Diacerein

object_name: type 2 diabetes mellitus


subject: CHEBI:94708

object_name: diabetes mellitus


subject: CHEBI:94708

object_name: Complications of Diabetes Mellitus


subject: GTOPDB:11132

subject_name: otilimab

object_name: severe acute respiratory syndrome


subject: UNII:Y8127R3VCH

subject_name: Otilimab


subject: UMLS:C4043330


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:135935

subject_name: Tapentadol

object_name: herpes zoster


subject: CHEBI:135935

object_name: postherpetic neuralgia


subject: CHEBI:135935

object_name: neuralgia


subject: CHEBI:135935

object_name: Neuralgia, CTCAE


subject: CHEBI:135935

object_name: diabetic neuropathy


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Extrapulmonary Small Cell Carcinoma


subject: UMLS:C3641122


subject: UMLS:C3179143

subject_name: Nicotine Replacement Products

object_name: Tabagism


subject: CHEBI:135928

subject_name: Doripenem

object_name: pneumonia


subject: CHEBI:135928

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Hypercapnia


subject: CHEBI:22652

object_name: Hypoxemia


subject: CHEBI:22652

object_name: Hypoxia, CTCAE


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:124959

subject_name: Tilarginine


subject: CHEBI:124959


subject: CHEBI:124959


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: PUBCHEM.COMPOUND:132201704

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:132201704

object_name: metastatic melanoma


subject: UMLS:C5706411

subject_name: Anti-CLDN6/CD3 BiTE Antibody AMG 794

object_name: ovarian carcinoma


subject: UMLS:C5706411

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5706411

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:29708

subject_name: Zinc gluconate

object_name: Excessive gingival display


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: septic shock


subject: CHEBI:149504

object_name: cystic fibrosis


subject: CHEBI:6541

subject_name: Losartan


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: cancer


subject: UNII:4EQZ6YO2HI

object_name: neoplasm